Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Daniel Ambinder

Interventional & Structural Cards · UMSOM

View

Dr. Amit Goyal

Interventional & Structural Cards · UT Southwestern

View

Dr. David Cohen

Interventional & Structural Cards · Cardiovascular Research Foundation

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View

Dr. Brahmajee Nallamothu

Interventional Cardiology · UMHS

View

Dr. Felix Yang

EP · NYU Langone

View

Dr. Jennifer Rymer

Interventional & Peripheral Cards · Duke University

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.

    Apr 25, 2024DOI: 10.1161/cir.0000000000001232Journal ArticleAHA

    Written by: Laura J DavidsonGilbert H L TangEdwin C HoMarat FudimTiberio FrisoliAnton CamajMargaret T BowersSofia Carolina MasriPavan AtluriJoanna ChikwePeter J MasonJason C KovacicGeorge D DangasAmerican Heart Association Interventional Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stro

    Find these authors on Roon

    AC

    Dr. Anton Camaj

    Interventional & Structural Cards · ISMMS

    JC

    Dr. Joanna Chikwe

    Cardiac Surgery · Cedars-Sinai

    Summary

    Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options. The tricuspid valve is complex anatomically, lying adjacent to important anatomic structures such as the right coronary artery and the atrioventricular node, and is the passageway for permanent pacemaker leads into the right ventricle. In addition, the mechanism of tricuspid pathology varies widely between patients, which can be due to primary, secondary, or a combination of causes, meaning that it is not possible for 1 type of device to be suitable for treatment of all cases of tricuspid valve disease. To best visualize the pathology, several modalities of advanced cardiac imaging are often required, including transthoracic echocardiography, transesophageal echocardiography, cardiac computed tomography, and cardiac magnetic resonance imaging, to best visualize the pathology. This detailed imaging provides important information for choosing the ideal transcatheter treatment options for patients with tricuspid valve disease, taking into account the need for the lifetime management of the patient. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease.
    ACDr. Anton Camaj

    Dr. Anton Camaj

    Cardiology · Interventional Cardiology & Structural
    Icahn School of Medicine at Mount Sinai
    anton